ArticleCancer medicine2013

EGFR, KRAS, BRAF, and HER-2 molecular status in brain metastases from 77 NSCLC patients.

Claire Villalva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.